Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for EssilorLuxottica Unsponsored ADR (ESLOY : OTC)
 
 • Company Description   
EssilorLuxottica Soci?t? is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company's brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Soci?t?, formerly known as Essilor International Soci?t? Anonyme, is based in Paris, France.

Number of Employees: 203,791

 
 • Price / Volume Information   
Yesterday's Closing Price: $92.54 Daily Weekly Monthly
20 Day Moving Average: 117,391 shares
Shares Outstanding: 928.49 (millions)
Market Capitalization: $85,922.93 (millions)
Beta: 0.92
52 Week High: $186.81
52 Week Low: $91.44
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -2.04% -2.76%
12 Week -13.18% -15.56%
Year To Date -41.59% -46.41%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
147 rue de Paris Charenton-le-Pont
-
Paris,I0 94220
FRA		 ph: 33-01-49-77-42-24
fax: 33-1-49-77-43-24		 ir@essilorluxottica.com http://www.essilorluxottica.com
 
 • General Corporate Information   
Officers
Francesco Milleri - Chief Executive Officer and Chairman
Paul du Saillant - Deputy Chief Executive Officer
Jean-Luc Biamonti - Chairman
Marie-Christine Coisne-Roquette - Director
Jose Gonzalo - Director

Peer Information
EssilorLuxottica Unsponsored ADR (BJCT)
EssilorLuxottica Unsponsored ADR (CADMQ)
EssilorLuxottica Unsponsored ADR (APNO)
EssilorLuxottica Unsponsored ADR (UPDC)
EssilorLuxottica Unsponsored ADR (IMTIQ)
EssilorLuxottica Unsponsored ADR (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 297284200
SIC: 8880
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 928.49
Most Recent Split Date: (:1)
Beta: 0.92
Market Capitalization: $85,922.93 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 1.80%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $1.67
Current Fiscal Year EPS Consensus Estimate: $4.12 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 8.70% Last Dividend Paid: 05/11/2026 - $1.67
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 22.46
Trailing 12 Months: -
PEG Ratio: 2.58
Price Ratios
Price/Book: 1.92
Price/Cash Flow: 12.09
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/26 - -
03/31/26 - -
12/31/25 - -
ROA
06/30/26 - -
03/31/26 - -
12/31/25 - -
Current Ratio
06/30/26 - -
03/31/26 - -
12/31/25 - 0.99
Quick Ratio
06/30/26 - -
03/31/26 - -
12/31/25 - 0.70
Operating Margin
06/30/26 - -
03/31/26 - -
12/31/25 - -
Net Margin
06/30/26 - -
03/31/26 - -
12/31/25 - -
Pre-Tax Margin
06/30/26 - -
03/31/26 - -
12/31/25 - 11.21
Book Value
06/30/26 - -
03/31/26 - -
12/31/25 - 48.22
Inventory Turnover
06/30/26 - -
03/31/26 - -
12/31/25 - 3.25
Debt-to-Equity
06/30/26 - -
03/31/26 - -
12/31/25 - 0.17
Debt-to-Capital
06/30/26 - -
03/31/26 - -
12/31/25 - 14.71
 

Powered by Zacks Investment Research ©